3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
197
Leukemia
110
Lymphoma
90
Precursor Cell Lymphoblastic Leukemia-Lymphoma
86
Burkitt Lymphoma
52
Myelodysplastic Syndromes
47
Lymphoma, Mantle-Cell
47
Lymphoma, Large B-Cell, Diffuse
47
Lymphoma, Non-Hodgkin
46
Leukemia, Myelomonocytic, Acute
30
Lymphoma, Follicular
29
Leukemia, Monocytic, Acute
29
Recurrence
25
Congenital Abnormalities
25
Leukemia, Erythroblastic, Acute
24
Lymphoma, Large-Cell, Immunoblastic
23
Leukemia, Megakaryoblastic, Acute
23
Blast Crisis
21
Hodgkin Disease
20
Leukemia, Lymphocytic, Chronic, B-Cell
18
Leukemia, Myelomonocytic, Chronic
17
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
17
Lymphoma, B-Cell, Marginal Zone
15
Anemia, Refractory, with Excess of Blasts
15
Leukemia, Myeloid, Accelerated Phase
13
Leukemia, Biphenotypic, Acute
13
Leukemia, Myeloid, Chronic-Phase
12
Dendritic Cell Sarcoma, Interdigitating
12
Myeloproliferative Disorders
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Interventions
Etoposide
3
Dexamethasone
2
Cyclophosphamide
2
Alemtuzumab
2
tocilizumab
1
sintilimab
1
pegaspargase
1
Whole-Body Irradiation
1
Vincristine
1
Prednisone
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Methotrexate
1
Gemcitabine
1
EPOCH protocol
1
Doxorubicin
1
Cytarabine
1
Calcium Dobesilate
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Lymphohistiocytosis, Hemophagocytic
×
Cytarabine
×
Clear all
NCT00368355
2020-01-21
MOHEL
Baylor College of Medicine
Phase 2
Completed
46 enrolled
12 charts